Back to search
FDAFDA · Food and drugs·Recall number Z-2793-2026

SafeOp Patient Interface, REF: AIX11240, part of SafeOp 3: Neural Informatix System

Published July 29, 2026 · Recall initiated: May 13, 2026

Summary

FDA records medical device Class II recall Z-2793-2026, published July 29, 2026 and initiated May 13, 2026. Recalling firm: Alphatec Spine, Inc.; Status: Ongoing; Reported quantity: 3; Lot: UDI-DI: 00190376517506. System Set ID/Patient Interface Serial Number: 2007716/ DG106225, 2005498/ DG106220, 2005490/ DG106230. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Intraoperative neuromonitoring device, due to a software issue, may experience loss or interruption of triggered electromyography (tEMG) functionality during use, displaying as system faults, loss of communication between the Patient Interface and Tablet, and prompts requiring system reboot; may result in increased operative time and surgical plan change.

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Alphatec Spine, Inc.
Distributor
US Nationwide distribution in the states of TX, MO, IN.
Lot
UDI-DI: 00190376517506. System Set ID/Patient Interface Serial Number: 2007716/ DG106225, 2005498/ DG106220, 2005490/ DG106230
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was SafeOp Patient Interface, REF: AIX11240, part of SafeOp 3: Neural Informatix System recalled?

Yes. FDA published recall Z-2793-2026 on July 29, 2026. Reported hazard: Intraoperative neuromonitoring device, due to a software issue, may experience loss or interruption of triggered electromyography (tEMG) functionality during use, displaying as system faults, loss of communication between the Patient Interface and Tablet, and prompts requiring system reboot; may result in increased operative time and surgical plan change.

What should I do if I have this product?

Voluntary: Firm initiated